|1.||Khalifa, Sherief I: 2 articles (08/2014 - 02/2014)|
|2.||Fahmy, Hesham: 2 articles (08/2014 - 02/2014)|
|3.||Szymanski, Pawel T: 2 articles (08/2014 - 02/2014)|
|4.||Ahmed, Safwat A: 2 articles (08/2014 - 02/2014)|
|5.||Radwan, Mohamed M: 2 articles (08/2014 - 02/2014)|
|6.||Oppenheim, Ariella: 2 articles (08/2011 - 04/2010)|
|7.||Klenk, Hans-Dieter: 2 articles (08/2007 - 08/2003)|
|8.||Li, Weiming: 1 article (01/2016)|
|9.||Hou, Yingchun: 1 article (01/2016)|
|10.||He, Shuixiang: 1 article (01/2016)|
01/01/1989 - "Earlier studies on the tumorigenicity of Vero monkey kidney cells were extended to various passage levels of BSC-1 aneuploid and CV-1 diploid monkey kidney cells in order to establish the effect of prolonged in vitro culture on the oncogenic potential of African green monkey kidney cells. "
11/01/1985 - "Studies on the tumorigenicity of Vero kidney cells of Cercopithecus aethiops monkey origin were extended to various passage levels of BSC-1 aneuploid cells and to low passage CV-1 diploid cells (derived also from C. "
12/01/1991 - "In one approach, we used established CV-1 cell lines which constitutively express the small-t gene, and study of the EII-early promoter was afforded by infection of an EIA-negative adenovirus type 5 variant. "
08/26/2011 - "Here we show that de novo Plvap/PV1 expression in CV-1 green monkey epithelial cells significantly reduces the ability of SV40 virus to establish productive infection, when cells are incubated with low concentrations of the virus. "
01/01/2011 - "Infection of CV-1 cells by GP42-H1 resulted in cell surface expression of the HA protein. "
02/01/2005 - "Productive virus infection in vitro was observed in MB-49 cells, although at somewhat lower efficiency than in African Green Monkey kidney CV-1 cells (American Type Culture Collection, Manassas, Virginia). "
12/05/2004 - "SV40 was detected in 2/4 cages tested where mixed infection of SV40 and adenoviruses was observed after inoculation of virions concentrated from cage waste in CV-1 cells. "
07/30/2003 - "In cytotoxicity assays, treatment of cells with varying concentrations of AZT induced a dose-dependent inhibition of cell growth of the human carcinoma lines DU-145 (prostate; IC50 at 24 microM), MCF-7 (breast; IC50 at 22 microM), and CX-1 (colon; IC50 at 23 microM), yet caused no significant effect on the growth of the control epithelial cell line CV-1 (monkey kidney) at a concentration as high as 50 microM AZT. "
05/01/2000 - "In the pancreatic carcinoma cell line CRL-1420, but not in normal African green monkey kidney cell line CV-1, it is selectively accumulated in mitochondria. "
09/26/1997 - "Compounds with such a unique double-conjugate structure were found to inhibit the growth of several tumor cell lines, such as colon carcinoma CX-1, and to exhibit relatively low toxicity against normal kidney cell line CV-1 (e.g., IC50(CX-1) = 50 nM, IC50(CV-1) = 17.3 microM; selectivity index = 346 for compound 5). "
03/15/1994 - "In vitro testing showed that AA1 was 10 times more toxic to the carcinoma cell line CX-1 than to the normal epithelial cell line CV-1. "
01/01/1990 - "The synergism between A and B is carcinoma selective when the ELA cells (the target) are compared to CV-1, an untransformed African green monkey kidney epithelial line. "
|4.||Hepatocellular Carcinoma (Hepatoma)
10/01/2001 - "Site-directed mutagenesis of this DR-4 abolished activity in reporter gene assays in the chicken hepatoma cells leghorn male hepatoma as well as transactivation of the 240-bp PBRU by CXR in CV-1 cells. "
06/15/1998 - "Lipid extracts of hepatoma cells or of liver or kidney stimulated expression of the reporter; extracts of CV-1 cells were far less effective. "
12/05/1995 - "Transfection assays in hepatoma H4-II-E-C3 and CV-1 cells indicated that this inhibition is mediated by TR in a ligand-dependent fashion. "
01/10/1995 - "The alternating sequence can act as a positive regulatory element in transient transfection assays in hepatoma cell lines, but not in CV-1 (monkey kidney) cells, suggesting that it can act as a tissue-specific regulatory element. "
03/01/1994 - "The ADH2 promoter directed substantial CAT expression in H4IIE-C3 cells (rat hepatoma) and in HeLa cells, but only minimal expression in CV-1 cells (monkey kidney fibroblasts). "
|5.||Breast Neoplasms (Breast Cancer)
04/01/2011 - "We constituted such an OC mixture containing 15 different components in environmentally relevant proportions and assessed its proliferative effects in four breast cancer cell lines (MCF-7, T47D, CAMA-1, MDAMB231) and in non-cancerous CV-1 cells. "
06/01/2008 - "SXR augmented ER-mediated transcription in the presence of E2 in MCF-7 breast cancer-derived cells and CV-1 fibroblast-derived cells. "
09/06/2002 - "Gel mobility shift assays revealed strong TEF-1 factor binding to one site using nuclear extracts from CV-1 cells and from the human breast cancer cell line MCF-7. "
10/11/2002 - "In the present study, we used [3H]norethisterone to explore the bioconversion of this compound to A-ring reduced metabolites in African Green Monkey Kidney CV-1 cells and breast cancer T-47D cells. "
03/01/2008 - "Human breast cancer cell line MCF-7 was co-transfected with Gal4-fused hERalpha and corresponding reporter plasmid; African green monkey kidney cell line CV-1 was co-transfected with rERalpha and reporter gene. "
|1.||DNA (Deoxyribonucleic Acid)
|2.||Tumor Viral Antigens (Large T Antigen)
|4.||Cytochrome P-450 CYP1A1 (CYP1A1)
|5.||Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
|10.||Epidermal Growth Factor (EGF)